Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
36.88
0.37 (1.01%)
At close: Aug 15, 2025, 3:59 PM
36.87
-0.03%
After-hours: Aug 15, 2025, 04:10 PM EDT

Harmony Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
145.49M 128.85M 181.47M 34.6M
Depreciation & Amortization
24.11M 24.36M 23.39M 18.84M
Stock-Based Compensation
42.6M 31.7M 26.17M 15.66M
Other Working Capital
n/a 46.55M 12.87M 15.46M
Other Non-Cash Items
36.91M 12.85M 3.49M 2.68M
Deferred Income Tax
-29.3M -13.42M -85.94M 26.15M
Change in Working Capital
n/a 35.03M -4.11M 631K
Operating Cash Flow
219.82M 219.39M 144.47M 98.56M
Capital Expenditures
-1.15M -312K -40.17M -100.3M
Cash Acquisitions
-33.07M -36.97M 141.83M -100M
Purchase of Investments
-105.29M -127.47M -110.73M n/a
Sales Maturities Of Investments
98.53M 118.31M 9.07M n/a
Other Investing Acitivies
-26.5M n/a -141.83M 100M
Investing Cash Flow
-67.48M -46.44M -141.83M -100.3M
Debt Repayment
-15M -1.25M -2M -500K
Common Stock Repurchased
n/a -100M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4M -3.79M 8.84M -22.08M
Financial Cash Flow
-11M -105.55M 6.84M 7.42M
Net Cash Flow
141.34M 67.4M 9.47M 5.68M
Free Cash Flow
218.67M 219.07M 104.29M -1.74M